Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2003
12/17/2003EP1370685A2 Diagnosis of diseases associated with dna repair
12/17/2003EP1370684A2 Polynucleotides related to colon cancer
12/17/2003EP1370683A2 mRNA AMPLIFICATION
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370681A2 Methods using fluorescence energy transfer probes for detecting cleavage of nucleic acids
12/17/2003EP1370680A2 Method for the detection and measurement of biomass
12/17/2003EP1370679A2 Methods of making and uses of compositions that modulate intronic region-encoded protein function
12/17/2003EP1370676A2 Mouse cytokine receptor
12/17/2003EP1370674A2 Enzymes having alpha amylase activity and methods of use thereof
12/17/2003EP1370665A2 Methods for isolating genes from microorganisms
12/17/2003EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370657A2 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
12/17/2003EP1370655A2 Secreted human proteins
12/17/2003EP1370653A1 Preparation of calibrants and use thereof in the quantification of nucleotide sequences of interest
12/17/2003EP1370651A1 70 human secreted proteins
12/17/2003EP1370647A2 A dna molecule encoding a variant paraoxonase and uses thereof
12/17/2003EP1370644A2 Materials and methods for the induction of premature chromosome condensation
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370579A1 Matrix gene expression in chondrogenesis
12/17/2003EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/17/2003EP1370572A2 Mitochondrial membrane permeabilization by hiv-1 vpr and methods of screening
12/17/2003EP1370354A2 Complex element micro-array and methods of use
12/17/2003EP1228241B1 Genetic test to determine non-responsiveness to statin drug treatment
12/17/2003EP1183102B1 The use of microfluidic systems in the electrochemical detection of target analytes
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP1102781B1 New cofactors for methyltransferases
12/17/2003EP1007074B1 Hypothalamus-specific polypeptides
12/17/2003EP0956349B1 Synthetic hpv16 virus-like particles
12/17/2003EP0837947B1 Toxicity detection
12/17/2003EP0792363B1 Novel pesticidal proteins and strains
12/17/2003EP0723549B1 Nucleic acid purification compositions and methods
12/17/2003EP0672131B1 A novel cell cycle control protein
12/17/2003EP0655086B1 An improved system for electronically monitoring and recording cell cultures
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003CN2592649Y Small-area reactor biochip
12/17/2003CN1462367A Biosensor
12/17/2003CN1461811A Designing method of oligonucleotide probe
12/17/2003CN1461810A Biological testing strip
12/17/2003CN1461809A Restrictive amplification method
12/17/2003CN1461806A Human leukemia related reverse transcript virus gene genome nucleic acid sequence and its application
12/17/2003CN1131320C Method for in-solution quenching of fluorescently labeled oligonucleotide probes
12/17/2003CN1131319C Detection equipment for cell contact inhibition, its preparation method and application
12/17/2003CN1131318C Optical immobilizing method for piezoelectric sensing medium of enzyme and microbe
12/17/2003CN1131301C Composite enzymatic sensitive film containing nanometer silver sol and its preparation and use
12/17/2003CN1131240C Chromosome 21 gene marker, compositions and methods using same
12/16/2003USRE38352 Evaluating blood sample for HIV reverse transcriptase having mutation at codon 215 correlating with accelerated immunologic decline
12/16/2003US6664442 Screening for modulator of alzheimer's disease; obtain human, administer mdulator, monitor and evaluate humans response to modulator
12/16/2003US6664441 Compound assay
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664379 Nuclease inhibitor cocktail
12/16/2003US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6664103 Chemically assembled nano-scale circuit elements
12/16/2003US6664096 Nutrient broths for use in the propagation of microorganism
12/16/2003US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof
12/16/2003US6664081 Diagnostic kits; genetic engineering
12/16/2003US6664080 TaqMan™-PCR for the detection of pathogenic E. coli strains
12/16/2003US6664079 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences
12/16/2003US6664074 Use of yacM and yqeJ, essential bacterial genes and polypeptides and their use
12/16/2003US6664073 Contacting with cystathionine beta-synthase, L-serine, and cystathionine beta-lyase to catalyze the cyclical conversion of homocysteine to cystathionine and the reconversion of cystathionine to homocysteine; pyruvate and NH3
12/16/2003US6664068 Antibodies, antiapoptotic agents
12/16/2003US6664065 Measuring viral reverse transcriptase activity
12/16/2003US6664064 Number of repeat sequences which are present in a sample is determined by means of melting temperature analysis of the hybridization product of the target nucleic acid with a hybridization probe
12/16/2003US6664063 Methods for separating,fractionating and analyzing gene of virus existing in hydrosphere
12/16/2003US6664062 Thymidylate synthase gene sequence variances having utility in determining the treatment of disease
12/16/2003US6664061 Gene expression of DNA sequences
12/16/2003US6664060 Arrays with mask layers and methods of manufacturing same
12/16/2003US6664059 Assay for propensity for canine malignant hyperthermia
12/16/2003US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
12/16/2003US6664057 Hybridization of probe; diagnosis of breast cancer
12/16/2003US6664056 Analyzing blood sample from pregnant human; obtain blood, remove cells, recover nucleotide sequences, determine genetic profile of fetus
12/16/2003US6664055 Diagnosing mood/psychological disorders in humans; obtain sample, monitor allelic genotype or phenotype, monitor pattern of kainate receptor protein, compare to control, evaluate for mood/psychological disorder
12/16/2003US6664053 Identification of a region of the major surface glycoprotein (MSG) gene of human Pneumocystis carinii
12/16/2003US6664052 Genetic polymorphism in a complement receptor
12/16/2003US6664051 Fixation of nucleotide derivatives to solid carrier
12/16/2003US6664050 Assaying a sample using an antibody specific to an adenovirus type 36p to test for the presence of the adenovirus; thus testing whether the person has been or is infected with adenovirus type 36p
12/16/2003US6664048 Combination of selection steps used to detect clones that express interacting molecules from false positive clones.
12/16/2003US6664047 Aza-benzazolium containing cyanine dyes
12/16/2003US6664046 mRNA splice variants can be discriminated from the predominant splice variants which encode inactive forms based on the presence of the beta region, the 182 nucleotide deletion encompassing exon 7 and exon 8. present invention
12/16/2003US6664045 PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms
12/16/2003US6664042 Determining viral load in double negative T cells
12/16/2003US6664041 Method for preparing a viral extract containing HIV-II RNA
12/16/2003US6664039 Having very long chain fatty acid coA synthetase activity; identifying a compound that inhibits the thioesterification activity of VLCFA coA-syn
12/16/2003CA2214359C Dna diagnostics based on mass spectrometry
12/16/2003CA2202167C Molecular tagging system
12/16/2003CA2026809C Haloperoxidase acid optimum chemiluminescence assay system
12/14/2003CA2432496A1 Diagnostic and therapeutic uses of sufu gene
12/11/2003WO2003103017A2 Method and system of determining chamber seasoning condition by optical emission
12/11/2003WO2003102849A1 Method for analysis of transcription variations in a set of genes
12/11/2003WO2003102602A2 Dna sensor arrangement and method for measuring the impedance in a dna sensor arrangement
12/11/2003WO2003102595A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
12/11/2003WO2003102590A1 Methods of detecting target molecules and molecular in teractions
12/11/2003WO2003102588A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
12/11/2003WO2003102587A1 Disc1 partners